Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment

Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni, Sabrina Croce, Isabelle Ray-Coquard, Fatma Guermazi, Biagio Paolini, Félix Blanc-Durand, Axel Lecesne, Valentina Chiappa, Angelo Paolo Dei Tos, Paolo Giovanni Casali

Clin Cancer Res (2023) 29 (22): 4679–4684.

https://doi.org/10.1158/1078-0432.CCR-23-0692

Published: 14 November 2023

View article titled, Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment

Journal Articles

Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study

Marco Fiore, Silva Ljevar, Sandro Pasquali, Daniele Morelli, Dario Callegaro, Roberta Sanfilippo, Marta Barisella, Claudia Sangalli, Rosalba Miceli, Alessandro Gronchi

Clin Cancer Res (2023) 29 (3): 614–620.

https://doi.org/10.1158/1078-0432.CCR-22-2897

Published: 01 February 2023

View article titled, Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study

Includes: Supplementary data

Journal Articles

Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors

Roberta Sanfilippo, Chiara Fabbroni, Giovanni Fucà, Elena Fumagalli, Carlo Morosi, Marta Sbaraglia, Alessandro Gronchi, Paola Collini, Angelo P. Dei Tos, Paolo G. Casali

Clin Cancer Res (2020) 26 (20): 5534–5538.

https://doi.org/10.1158/1078-0432.CCR-20-1191

Published: 15 October 2020

View article titled, Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors

Includes: Supplementary data

Journal Articles

Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Roberta Frapolli, Ezia Bello, Marianna Ponzo, Ilaria Craparotta, Laura Mannarino, Sara Ballabio, Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo Giovanni Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D'Incalci

Clin Cancer Res (2020) 26 (5): 1199.

https://doi.org/10.1158/1078-0432.CCR-20-0172

Published: 02 March 2020

View article titled, Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Journal Articles

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Clin Cancer Res (2019) 25 (24): 7565–7575.

https://doi.org/10.1158/1078-0432.CCR-19-0976

Published: 13 December 2019

View article titled, Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Includes: Supplementary data

Journal Articles

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Clin Cancer Res (2019) 25 (17): 5295–5300.

https://doi.org/10.1158/1078-0432.CCR-19-0288

Published: 03 September 2019

View article titled, Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Includes: Supplementary data

Journal Articles

Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors

Roberta Frapolli, Elena Tamborini, Emanuela Virdis, Ezia Bello, Eva Tarantino, Sergio Marchini, Federica Grosso, Roberta Sanfilippo, Alessandro Gronchi, Juan Carlos Tercero, Gabriella Peloso, Paolo Casali, Silvana Pilotti, Maurizio D'Incalci

Clin Cancer Res (2010) 16 (20): 4958–4967.

https://doi.org/10.1158/1078-0432.CCR-10-0317

Published: 13 October 2010

View article titled, Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors

Journal Articles

Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma

Tiziana Negri, Emanuela Virdis, Silvia Brich, Fabio Bozzi, Elena Tamborini, Eva Tarantino, Genny Jocollè, Giuliana Cassinelli, Federica Grosso, Roberta Sanfilippo, Patrizia Casalini, Angela Greco, Marco A. Pierotti, Silvana Pilotti

Clin Cancer Res (2010) 16 (14): 3581–3593.

https://doi.org/10.1158/1078-0432.CCR-09-2912

Published: 14 July 2010

View article titled, Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma

Includes: Supplementary data

NARROW

Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment

Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study

Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors

Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors

Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only